Equities researchers at Cantor Fitzgerald issued their FY2025 EPS estimates for Celldex Therapeutics in a report issued on Tuesday, January 21st. Cantor Fitzgerald analyst K. Kluska forecasts that the ...
Brett Knoblauch, Cantor Fitzgerald head of digital asset research, joins 'Power Lunch' to discuss the energy needed to power AI in Stargate deal and the winners from it.
Some results have been hidden because they may be inaccessible to you